The report on the global platinum based cancer drug market provides qualitative and quantitative analysis for the period from 2021-2030. The report predicts the global platinum based cancer drug market to grow with a CAGR of Over 3% over the forecast period from 2023-2030. The study on platinum based cancer drug market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
The report on platinum based cancer drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global platinum based cancer drug market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global platinum based cancer drug market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
2. Complete coverage of all the segments in the platinum based cancer drug market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global platinum based cancer drug market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
The report on platinum based cancer drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global platinum based cancer drug market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global platinum based cancer drug market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- Increasing prevalence of cancer.
- Increased demand for cancer drug due to rise in colorectal, prostate, cervical, and breast cancer patients.
2) Restraints
- Side effects of drugs.
- Stringent government rules and regulations.
3) Opportunities
- Investment of various companies in research and development in the emerging market.
Research Methodology
A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include
1. Executives working with leading companies in the market under review2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.The secondary sources of the data typically include
1. Company reports and publications2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global platinum based cancer drug market is segmented on the basis of type, application, and distribution channel.The Global Platinum Based Cancer Drug Market by Type
- Cisplatin
- Oxaliplatin
- Carboplatin
- Others
The Global Platinum Based Cancer Drug Market by Application
- Colorectal Cancer
- Ovarian Cancer
- Lung Cancer
- Others
The Global Platinum Based Cancer Drug Market by Distribution Channel
- Hospital-based Pharmacies
- Retail Pharmacies
- Online Pharmacies
Company Profiles
The companies covered in the report include- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Sanofi
- Eli Lilly and Company
- Accord Healthcare
- Guizhou Yibai Pharmaceutical Co., Ltd.
- Bayer AG
- Qilu Pharmaceutical Co., Ltd.
- Dr. Reddy’s Laboratories Ltd.
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the platinum based cancer drug market.2. Complete coverage of all the segments in the platinum based cancer drug market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global platinum based cancer drug market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Global Platinum Based Cancer Drug Market Overview
Chapter 5. Global Platinum Based Cancer Drug Market by Type
Chapter 6. Global Platinum Based Cancer Drug Market by Application
Chapter 7. Global Platinum Based Cancer Drug Market by Distribution Channel
Chapter 8. Global Platinum Based Cancer Drug Market by Region 2023-2030
Chapter 9. Company Profiles and Competitive Landscape
Companies Mentioned
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Sanofi
- Eli Lilly and Company
- Accord Healthcare
- Guizhou Yibai Pharmaceutical Co., Ltd.
- Bayer AG
- Qilu Pharmaceutical Co., Ltd.
- Dr. Reddy’s Laboratories Ltd.
